Buy Cabergoline (Dostinex) tablets online
How and where to order Dostinex, Cabaser, Cabgolin (Cabergoline) 0.25 mg, 0.5 mg, 1 mg tablets online on the International Consumer Support for Infertility website:
| Shop: | DFH PHARMACY - 10% discount coupon DFH10 |
| Sellers: | CABERGOLINE STORES |
| Prices: | from $2.90 per pill |
| Forms: | 0.25 mg, 0.5 mg, 1 mg tablets |
| Quantity: | 4-90 pills |
| Type: | Cabaser brand, Cabgolin brand, Dostinex brand and generics |
| Payment: | Visa, Mastercard, AmEx, Bitcoin |
| Delivery: | Regular and express mail service |
| Shipping: | Worldwide, including USA, UK, Europe, Canada, Australia |
Indications and usage:
Cabergoline tablets are indicated for the treatment of:
Dosage and administration:
The recommended dosage of Dostinex (Cabergoline) tablets for initiation of therapy is 0.25 mg twice a week. Dosage may be increased by 0.25 mg twice weekly up to a dosage of 1 mg twice a week according to the patient's serum prolactin level. Before initiating treatment, cardiovascular evaluation should be performed and echocardiography should be considered to assess for valvular disease.
Dosage increases should not occur more rapidly than every 4 weeks, so that the physician can assess the patient's response to each dosage level. If the patient does not respond adequately, and no additional benefit is observed with higher doses, the lowest dose that achieved maximal response should be used and other therapeutic approaches considered. Patients receiving long term treatment with Dostinex should undergo periodic assessment of their cardiac status and echocardiography should be considered.
After a normal serum prolactin level has been maintained for 6 months, cabergoline may be discontinued, with periodic monitoring of the serum prolactin level to determine whether or when treatment with this medication should be reinstituted. The durability of efficacy beyond 24 months of therapy with Cabergoline (Dostinex) has not been established
Overdosage:
Overdosage by cabergoline might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken if necessary.
Dosage forms and strengths:
Contraindications:
Cabergoline (Dostinex) tablets are contraindicated in patients with:
Warnings and precautions:
Adverse reactions, side effects:
The most frequently reported adverse experiences with cabergoline tablets have been abnormal or unusual thoughts, heart valve and related disorders e.g. inflammation (pericarditis) or leaking of fluid in the pericardium (pericardial effusion), development of a widespread itchy rash, difficulty breathing with or without wheezing, feeling faint, unexplained swelling of the body or tongue or any other symptoms which appear to come on rapidly after taking this medication and make you feel unwell.
To report suspected side effects of Dostinex (Cabergoline) tablets contact Pfizer pharmaceutical company or your local FDA.
Drug interactions:
Some medication can reduce the effectiveness of cabergoline, these include:
Some medication can increase the amount of cabergoline in your blood and so could increase the side effects, these include:
Related medications:
Use in specific populations:
Pregnancy
There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Dostinex should be used during pregnancy only if clearly needed.
Nursing mothers
It is not known whether cabergoline is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from this medication, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Use of Dostinex for the inhibition or suppression of physiologic lactation is not recommended.
The prolactin-lowering action of cabergoline suggests that it will interfere with lactation. Due to this interference with lactation, this drug should not be given to women postpartum who are breastfeeding or who are planning to breastfeed.
Pediatric use
Safety and effectiveness of Cabergoline (Dostinex, Cabaser, Cabgolin) tablets in pediatric patients have not been established.
Geriatric use
Clinical studies of this medication did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Information for patients:
Patients should be instructed to notify their physician if they suspect they are pregnant, become pregnant, or intend to become pregnant during therapy. A pregnancy test should be done if there is any suspicion of pregnancy and continuation of treatment should be discussed with their physician.
Patients should notify their physician if they develop shortness of breath, persistent cough, difficulty with breathing when lying down, or swelling in their extremities.
Patients should be alerted to the possibility that patients may experience intense urges to spend money uncontrollably, intense urges to gamble, increased sexual urges, and other intense urges and the inability to control these urges while taking cabergoline. Advise patients to inform their healthcare provider if they develop new or increased uncontrolled spending, gambling urges, sexual urges, or other urges while being treated with Dostinex pills.
Where to buy cabergoline online:
To purchase Dostinex, Cabaser, Cabgolin (Cabergoline) 0.25 mg, 0.5 mg, 1 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.
Here is a list of popular medications containing cabergoline as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
| Trade name of the drug | Pharmaceutical forms and doses | Companies |
| Cabaser | ||
| Cabergolina | ||
| Cabgolin | ||
| Dostinex | ||
| Sostilar |